4/16
08:00 am
ixhl
Incannex Healthcare Inc. Quarterly Update, Q1 2024
High
Report
Incannex Healthcare Inc. Quarterly Update, Q1 2024
2/28
12:58 pm
ixhl
CNDB and SOND among mid-day movers [Seeking Alpha]
Medium
Report
CNDB and SOND among mid-day movers [Seeking Alpha]
2/28
07:30 am
ixhl
Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
High
Report
Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
2/16
07:30 am
ixhl
Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
Low
Report
Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
2/4
09:26 am
ixhl
We're Keeping An Eye On Incannex Healthcare's (NASDAQ:IXHL) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're Keeping An Eye On Incannex Healthcare's (NASDAQ:IXHL) Cash Burn Rate [Yahoo! Finance]
2/1
07:30 am
ixhl
Clarion Clinics Open for Psychedelic-Assisted Treatments
High
Report
Clarion Clinics Open for Psychedelic-Assisted Treatments
1/24
04:05 pm
ixhl
Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis
Medium
Report
Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis